Protective effect of Porphyromonas gingivalis outer membrane vesicles against bactericidal activity of human serum.
The present study was undertaken to evaluate the effect of Porphyromonas gingivalis outer membrane vesicles on the bactericidal activity of human serum. Human serum was pretreated with extracellular vesicles and then incubated with a cell suspension of Capnocytophaga ochracea. After 2 h at 37 degrees C, the percent viability of C. ochracea was determined by cultivation on blood agar plates. At a final concentration of 0.3 mg/ml, outer membrane vesicles completely inhibited the serum bactericidal activity against C. ochracea. Boiling the vesicles prevented this inhibition. However, partial inhibition of the serum lethal action was obtained when a higher concentration (1.5 mg/ml) of boiled vesicles was used, which indicates the involvement of both heat-labile and heat-stable components associated with vesicles. Combining vesicles at a suboptimal concentration (0.1 mg/ml) with a reducing agent brought back inhibition of the bactericidal activity, whereas combining vesicles at an optimal concentration (0.3 mg/ml) with a thiol-blocking reagent caused a restoration of the bactericidal activity. When a purified preparation of P. gingivalis lipopolysaccharides was used instead of vesicles, inhibition of the bactericidal activity was also observed. These results indicate that the lipopolysaccharides and the proteolytic enzyme(s) associated with P. gingivalis outer membrane vesicles are likely to represent the heat-stable and the heat-labile components, respectively. It is possible that outer membrane vesicles released by P. gingivalis protect other bacterial species from complement action, thus favoring the pathogenic process of periodontal disease.
Grenier
D
D
Département de Santé Buccale, Faculté de Médecine Dentaire, Université de Montréal, Québec, Canada.
Bélanger
M
M
D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001439:Bacteroides / Q000276:immunology*; D001770:Blood Bactericidal Activity; D002206:Capnocytophaga / Q000254:growth & development; D015169:Colony Count, Microbial; D005455:Fluorescent Antibody Technique; D006801:Humans; D008070:Lipopolysaccharides / Q000276:immunology; D008623:Mercaptoethanol / Q000276:immunology
D001425:Bacterial Outer Membrane Proteins; D008070:Lipopolysaccharides; D008623:Mercaptoethanol